Pay Docs for Talking About Quality, Union Official Says

WASHINGTON (MedPage Today) — Physicians and other providers should be paid for explaining to patients how healthcare decisions are made and why quality measurement is important, according to Gerry Shea, of the AFL-CIO.

Off-Label Stent Use Drives Up Healthcare Costs

(MedPage Today) — Drug-eluting stents have driven up the cost of healthcare, not only because they are more expensive than bare-metal stents, but also because they have changed the pattern of care, researchers reported.

FDA Okays New Drug for Advanced Prostate Ca

WASHINGTON (MedPage Today) — The FDA has approved abiraterone acetate (Zytiga) for treatment of late-stage, castration-resistant prostate cancer as a combination therapy with prednisone in patients who have received prior chemotherapy with docetaxel.

CEL-SCI receives no objection letter to initiate Phase III clinical trial of Multikine in Canada

CEL-SCI Corporation announced today that the Biologics and Genetic Therapeutics Directorate of Health Canada has issued a final “no objection” letter for CEL-SCI to be able to begin enrollment of patients for a Phase III clinical trial of Multikine in Canada.

Takeda, Affymax announce additional peginesatide Phase 3 study results in dialysis patients

Affymax, Inc. and Takeda Pharmaceutical Company Limited, today announced results of additional analyses from two Phase 3 studies of the investigational agent, peginesatide in chronic renal failure patients on dialysis with anemia.

MorphoSys reaches second clinical milestone with OncoMed Pharmaceuticals

MorphoSys AG announced today that it has received a milestone payment from OncoMed Pharmaceuticals in connection with the FDA acceptance of an IND for a HuCAL-derived, fully human antibody. The antibody OMP-18R5, which targets the Wnt signaling pathway, will be evaluated in a Phase 1 trial in the US in patients with advanced solid tumors.

Blockbuster Allergan Botox Settlement; $212 Million To California Man

In a huge settlement, $212 million dollars has been awarded to a victim of Botox, as Allergan the manufacturer, has conceded that the drug did in fact cause a California man brain damage and disability. However, this case took place in Virginia. Douglas Ray Jr., 67, filed suit against Allergan Inc…

Civilian And Military Aviation Biofuels: Companies To Highlight New Technologies And Markets At BIO’s World Congress On Industrial Biotechnology

Biofuel research and development companies will present progress in bringing new advanced biofuels to market, while military officials and civilian airline executives discuss industry requirements for readily available, cleaner fuels during BIO’s 8th annual World Congress on Industrial Biotechnology and Bioprocessing…

Medical Students Support Gift Ban; Urge Senate To Protect Patients

The Massachusetts House of Representatives has once again voted to repeal the state’s gift ban, which regulates interactions between physicians and the pharmaceutical industry. The American Medical Student Association (AMSA) urges the Massachusetts Senate to support the ban that clearly translates into better patient care…

Health Canada approves Eli Lilly’s Cymbalta for chronic low back pain treatment

Eli Lilly Canada announced today that Health Canada has approved Cymbalta for the management of chronic low back pain.